Patterns of red-cell transfusion use in obstetric practice in sweden 2003-2017: A nationwide study.


Journal

Vox sanguinis
ISSN: 1423-0410
Titre abrégé: Vox Sang
Pays: England
ID NLM: 0413606

Informations de publication

Date de publication:
Aug 2021
Historique:
revised: 30 12 2020
received: 15 09 2020
accepted: 30 12 2020
pubmed: 3 2 2021
medline: 16 10 2021
entrez: 2 2 2021
Statut: ppublish

Résumé

There is a paucity of data on patterns of red-cell transfusions in obstetrical care, but some studies have suggested an increase in transfusion rates during the last decade. The purpose of this study was to investigate maternal characteristics, temporal trends and hospital variations in red-cell use in a large contemporary obstetric cohort in Sweden. Nationwide observational cohort study of maternal red-cell transfusions for all deliveries in Sweden between 2003 and 2017. The proportion of deliveries that received red-cell transfusions was stable during the study period, although the number of red-cell units administered per delivery declined. Among transfused women, most received a low-volume transfusion of 1 or 2 units. Red-cell transfusion was more common among the nulliparous, for instrumental and caesarean deliveries, and with increased maternal age. We saw large variations in transfusion rates between hospitals in Sweden, despite adjusting for age and parity. In comparison to other high-resource countries we see a high proportion of deliveries with maternal red-cell transfusions. However, we do not see an increase in red-cell use over time.

Sections du résumé

BACKGROUND BACKGROUND
There is a paucity of data on patterns of red-cell transfusions in obstetrical care, but some studies have suggested an increase in transfusion rates during the last decade. The purpose of this study was to investigate maternal characteristics, temporal trends and hospital variations in red-cell use in a large contemporary obstetric cohort in Sweden.
STUDY DESIGN AND METHODS METHODS
Nationwide observational cohort study of maternal red-cell transfusions for all deliveries in Sweden between 2003 and 2017.
RESULTS RESULTS
The proportion of deliveries that received red-cell transfusions was stable during the study period, although the number of red-cell units administered per delivery declined. Among transfused women, most received a low-volume transfusion of 1 or 2 units. Red-cell transfusion was more common among the nulliparous, for instrumental and caesarean deliveries, and with increased maternal age. We saw large variations in transfusion rates between hospitals in Sweden, despite adjusting for age and parity.
CONCLUSIONS CONCLUSIONS
In comparison to other high-resource countries we see a high proportion of deliveries with maternal red-cell transfusions. However, we do not see an increase in red-cell use over time.

Identifiants

pubmed: 33528029
doi: 10.1111/vox.13074
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

821-830

Informations de copyright

© 2021 The Authors. Vox Sanguinis published by John Wiley & Sons Ltd on behalf of International Society of Blood Transfusion.

Références

Auvinen M-KZJ, Lassén E, Lubenow N, Seger Mollén A, Watz E, Wikman A, Edgren G: Patterns of Blood Use in Sweden from 2008 to 2017: A Nationwide Cohort Study.
Goel R, Chappidi MR, Patel EU, et al.: Trends in red blood cell, plasma, and platelet transfusions in the United States, 1993-2014. JAMA 2018; 319:825-7
Tinegate H, Chattree S, Iqbal A, et al.: Ten-year pattern of red blood cell use in the North of England. Transfusion 2013; 53:483-9
Liu S, Joseph KS, Bartholomew S, et al.: Temporal trends and regional variations in severe maternal morbidity in Canada, 2003 to 2007. J Obstetr Gynaecol Can 2010; 32(9):847-855.
Patterson JA, Roberts CL, Bowen JR, et al.: Blood transfusion during pregnancy, birth, and the postnatal period. Obstet Gynecol 2014; 123:126-33
Jakobsson M, Gissler M, Tapper AM: Risk factors for blood transfusion at delivery in Finland. Acta Obstet Gynecol Scand 2013; 92:414-20
So-Osman C, Cicilia J, Brand A, et al.: Triggers and appropriateness of red blood cell transfusions in the postpartum patient-a retrospective audit. Vox Sang 2010; 98:65-9
Cauldwell M, Shamshirsaz A, Wong TY, et al.: Retrospective surveys of obstetric red cell transfusion practice in the UK and USA. Int J Gynaecol Obstet 2017; 139:342-5
Stephens B, Sethna F, Crispin P: Postpartum obstetric red cell transfusion practice: A retrospective study in a tertiary obstetric centre. Aust N Z J Obstet Gynaecol 2018; 58:170-7
Cnattingius S, Ericson A, Gunnarskog J, et al.: A quality study of a medical birth registry. Scand J Soc Med 1990; 18:143-8
Zhao J, Rostgaard K, Hjalgrim H, Edgren G: The Swedish Scandinavian donations and transfusions database (SCANDAT3-S) - 50 years of donor and recipient follow-up. Transfusion (2020); 60(12):3019-27
Socialstyrelsen, 2020. https://sdb.socialstyrelsen.se/if_mfr_004/resultat.aspx (Last accessed 7th June 2020. 2020).
Enright S, Varadkar S, Demaio A, et al.: Antecedents of red cell transfusion in a large contemporary obstetric cohort. J Perinat Med 2019; 47:195-9
Shehata N, Chasse M, Colas JA, et al.: Risks and trends of red blood cell transfusion in obstetric patients: a retrospective study of 45,213 deliveries using administrative data. Transfusion 2017; 57:2197-205
Holm C, Langhoff-Roos J, Petersen KB, et al.: Severe postpartum haemorrhage and mode of delivery: a retrospective cohort study. BJOG 2012; 119:596-604
Patterson JA, Nippita TA, Randall D, et al.: Outcomes associated with transfusion in low-risk women with obstetric haemorrhage. Vox Sang 2018; 113:678-85
Prick BW, Jansen AJ, Steegers EA, et al.: Transfusion policy after severe postpartum haemorrhage: a randomised non-inferiority trial. BJOG 2014; 121:1005-14
Drayton BA, Patterson JA, Nippita TA, et al.: Red blood cell transfusion after postpartum haemorrhage and breastmilk feeding at discharge: A population-based study. Aust N Z J Obstet Gynaecol 2016; 56:591-8
Allen JG: The case for the single transfusion. N Engl J Med 1972; 287:984-5
Munoz M, Stensballe J, Ducloy-Bouthors AS, et al.: Patient blood management in obstetrics: prevention and treatment of postpartum haemorrhage. A NATA consensus statement. Blood Transfus 2019; 17:112-36
Kenny LC, Lavender T, McNamee R, et al.: Advanced maternal age and adverse pregnancy outcome: evidence from a large contemporary cohort. PLoS One 2013; 8:e56583
Jolly M, Sebire N, Harris J, et al.: The risks associated with pregnancy in women aged 35 years or older. Hum Reprod 2000; 15:2433-7
Jegasothy E, Patterson J, Randall D, et al.: Assessing the effect of risk factors on rates of obstetric transfusion over time using two methodological approaches. BMC Med Res Methodol 2018; 18:139
Patterson JA, Roberts CL, Isbister JP, et al.: What factors contribute to hospital variation in obstetric transfusion rates? Vox Sang 2015; 108:37-45

Auteurs

Anne Brynolf (A)

Department of Medicine, Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden.
Department of Anaesthesiology and Intensive Care, Södersjukhuset, Stockholm, Sweden.

Jingcheng Zhao (J)

Department of Medicine, Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden.

Agneta Wikman (A)

Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden.
Department of CLINTEC, Karolinska Institutet, Stockholm, Sweden.

Sara Öberg (S)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Anna Sandström (A)

Department of Medicine, Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden.
Department of Women's Health, Karolinska University Hospital, Stockholm, Sweden.

Gustaf Edgren (G)

Department of Medicine, Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden.
Department of Cardiology, Södersjukhuset, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH